Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 3670-4 (MIR3670-4) is a short (20-24 nucleotides) non-coding RNA molecule found in humans. Like other microRNAs, it is transcribed by RNA polymerase II as part of a primary transcript, processed by Drosha and Dicer nucleases into its mature form, and functions by guiding the RNA-induced silencing complex (RISC) to target complementary messenger RNAs. This typically results in inhibition of protein synthesis either by destabilizing the target mRNA or by repressing its translation. While microRNAs as a class are implicated in the regulation of diverse biological processes such as cell growth, differentiation, apoptosis, and immune responses, there is no currently available information linking MIR3670-4 specifically to any disease, biological specialty, or drug interaction in humans[4][2][6]. If further detailed characterization of MIR3670-4's biological roles, disease associations, or therapeutic uses is discovered, records and curated data may need to be updated.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 3670-4 (MIR3670-4).